Laurion Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-227,022
| Closed | -$2.07M | – | 582 |
|
|
2022
Q1 | $2.07M | Buy |
+227,022
| New | +$2.07M | 0.03% | 107 |
|
|
2019
Q2 | – | Sell |
-38,966
| Closed | -$1.85M | – | 910 |
|
|
2019
Q1 | $1.85M | Buy |
+38,966
| New | +$1.85M | 0.02% | 142 |
|
|
2017
Q4 | – | Sell |
-4,800
| Closed | -$233K | – | 1441 |
|
|
2017
Q3 | $233K | Buy |
+4,800
| New | +$233K | ﹤0.01% | 935 |
|
|
2017
Q2 | – | Sell |
-5,500
| Closed | -$249K | – | 1410 |
|
|
2017
Q1 | $249K | Buy |
+5,500
| New | +$249K | ﹤0.01% | 683 |
|
|
2016
Q4 | – | Sell |
-24,300
| Closed | -$917K | – | 913 |
|
|
2016
Q3 | $917K | Buy |
+24,300
| New | +$917K | 0.01% | 235 |
|
|
2016
Q1 | – | Sell |
-9,900
| Closed | -$241K | – | 882 |
|
|
2015
Q4 | $241K | Buy |
+9,900
| New | +$241K | ﹤0.01% | 453 |
|